Your browser is no longer supported. Please, upgrade your browser.
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.27%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.36%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter4.20%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y13.02%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year23.63%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range54.63 - 76.01 Perf YTD5.25%
Dividend0.93 P/FCF- EPS past 5Y- ROI- 52W High-5.58% Beta-
Dividend %1.30% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low31.38% ATR1.06
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.10 Volatility1.51% 1.39%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.08 Prev Close72.50
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume10.66M Price71.77
Recom- SMA20-1.38% SMA500.31% SMA2008.53% Volume21,803,500 Change-1.01%
Apr-01-15 06:04PM  What Are Aetnas Key Risks?
04:05PM  The Fed Effect A Twist in the Tale
02:29PM  Finding winners in the best, worst of 2015 market at CNBC
02:05PM  Why Is Pfizers Revenue Stream Declining?
01:50PM  This Sector Is Dominating The IPO Market In 2015
01:07PM  Utilities vs. health care in April
12:01PM  How to make it rain in April
09:55AM  How You Can Guard Against Volatility
Mar-31-15 09:43PM  Why the stock market is running on empty
04:06PM  Pfizers Global Vaccines, Oncology & Consumer Healthcare Segment
03:11PM  Biotech -Monthly reversal pattern in play at resistance
10:33AM  M&A drivers for 2015
10:14AM  The Bull Case: Supply & Demand Edition
09:45AM  Technical Market Outlook: Breadth, Momentum, Options, & Sectors
08:02AM  Quarter end scorecard
Mar-30-15 06:00PM  What to watch at the end of the quarter
05:06PM  Healthcare ETFs Moving On UnitedHealth Deal
02:06PM  Biopharmaceutical Business: Why Its Important for Pfizer
12:05PM  Must-Know: Aetnas Key Mergers and Acquisitions
10:19AM  These positions hurt hedge funds the most last week
09:06AM  Is the PharmacyclicsAbbVie Merger a Setup?
Mar-28-15 04:05AM  ETFs Capitalize on the Generic Industrys Growth
03:05AM  What Drives Generic Pharmaceuticals Valuation?
02:05AM  Generic Companies Are Fighting for Market Share
02:05AM  Specialty Generics: Why Are They Getting More Attention?
02:05AM  Affordable Pricing Is Driving the Generic Drug Market
02:05AM  How Aetna Generates Value for its Shareholders
01:05AM  Farallon Capital Increases Position in Covidien
01:05AM  The PharmacyclicsAbbVie Merger: What Are the Details?
01:05AM  How Does Aetna Compare with Its Peers in Valuation?
01:05AM  How the NAICs Capital Requirements Affect Aetna
01:04AM  How Does Aetna Compare to Its Peers in Medical Care Ratio?
01:04AM  How Aetna Plans to Improve Quality of Care and Reduce Costs
Mar-27-15 04:01PM  Pfizer: A Leading Pharmaceutical Company
02:05PM  Not another Bubble: Why the NASDAQ is a Different Index Now
Mar-26-15 01:06PM  Pisani sorts through volatile trading
12:00AM  The strong dollar will sting 1Q results
Mar-25-15 05:04PM  UnitedHealth Groups payment strategy evolved in 2014
03:51PM  Good time for investors to jump in: Pro
01:05PM  Why Is the Generics Industry Controlled by Regulations?
12:07PM  Bargaining Power Is in the Hands of the Distribution Industry
10:06AM  The PharmacyclicsAbbVie Merger: The Basics of Pharmacyclics
Mar-24-15 02:30PM  Here's how to protect your profits in biotech: Trader
07:34AM  Health check: Obamacare 5 years later
Mar-23-15 11:05AM  UnitedHealth Groups Optum segment: Earnings rose in 2014
10:32AM  3 Material Stocks to Avoid at Forbes
10:05AM  UnitedHealth Groups enrollments shifted in 4Q14 Market Realist
09:05AM  UnitedHealths government-sponsored enrollment rose in 4Q14 Market Realist
Mar-21-15 09:02AM  Will Stock Bears Be Left Behind?
Mar-20-15 07:27PM  The Week Ahead: Why Building the Wall of Worry Is Bullish at Forbes
05:58PM  Time for tactical seasonal sector maneuvers
05:04PM  What key risks does UnitedHealth Group face? Market Realist
04:05PM  Analyzing the Performance of Aetnas Business Segments in 4Q14 Market Realist
02:05PM  Aetnas Government-Sponsored Business Accounts for 38% of Revenue Market Realist
11:06AM  Viking Global Exited Its Position in AbbVie
Mar-19-15 04:04PM  OptumRx manages UNHs pharmacy benefit management business
01:06PM  Why the Generic Industrys Classification Is Still Evolving
01:01PM  Aetna Reported Revenue Growth in Its 4Q14 Earnings
12:04PM  UnitedHealth Groups OptumHealth what does it provide?
Mar-18-15 10:04PM  UnitedHealths operating expenses compared to its peers Market Realist
09:05PM  Understanding Johnson & Johnsons Ownership Structure
09:05PM  Paulson & Co. sells out its position in Aetna
11:05AM  What Risks Does Johnson & Johnson Face?
10:02AM  Advisers: Ask Your Clients How They Take Care of Their Health
Mar-17-15 05:06PM  How Is Aetnas Membership Distributed Across Its Key Markets? Market Realist
04:05PM  Whats UnitedHealth Groups strategy for international expansion? Market Realist
03:05PM  What are UnitedHealth Groups key business segments? Market Realist
01:06PM  Johnson & Johnson Invested in Research and Development
10:19AM  Sector Sidesteps Correction at Forbes
Mar-16-15 05:05PM  The Salix-Endo Proposal: Basics of the Transaction
01:58PM  Three trades to go before the closing bell at CNBC
12:56PM  Top 2nd-half trades: Disney & health care
11:50AM  Why are stocks in rally mode?
11:05AM  Johnson & Johnsons Revenue Stream Increased in 2014
Mar-15-15 01:05PM  Whats UnitedHealth Groups outlook for 2015? Market Realist
12:05PM  UnitedHealth Groups medical care ratio declined in 4Q14
11:05AM  UnitedHealths diversification strategy improved its performance
10:05AM  UnitedHealth Groups valuations compared to its peers Market Realist
09:05AM  UnitedHealth Groups OptumInsight improving medical care
Mar-14-15 09:11AM  Major Bull / Bear Demarcation Line
Mar-13-15 03:00PM  CNBC explains: Obamacare in 2015
08:46AM  These new meds could move stocks
Mar-12-15 07:05PM  Exploring Johnson & Johnsons Pharmaceuticals Segment
Mar-11-15 05:15PM  Top Sectors for Investors In a Turbulent Market at
04:30PM  Johnson & Johnson: A Leading Pharmaceuticals Company
04:05PM  UnitedHealth Group provides services to Medicare beneficiaries Market Realist
03:05PM  UnitedHealth Groups community and state-based insurance business Market Realist
08:09AM  Volatility hard-wired into markets: Okada
07:00AM  Health-Care Funds: Hale and Hearty at Morningstar
Mar-10-15 12:00PM  Integrating Apple Watch into US healthcare
10:29AM  Game changer for health research
09:31AM  UnitedHealth Group reported growth in its 4Q14 earnings
Mar-09-15 09:01AM  Hedge Fund Stress, Returns & Risk Yahoo Finance Contributors
Mar-06-15 07:44AM  Why nearly 200,000 of these good-paying jobs will go unfilled Yahoo Finance
Mar-05-15 09:06PM  Earnings Season Is Almost Over: Here Are The Sectors That Did The Best and Worst Yahoo Finance Contributors
05:19PM  This sector could be the best bet this year Talking Numbers
09:50AM  Portfolio Report Card: A Poorly Designed $863,309 Advisor Managed Account ETFguide
07:36AM  The FED, ObamaCare or The ECB - Which One Moves the Needle? Try the Risotto Al' Amarone Yahoo Finance Contributors
Mar-04-15 07:05PM  Parsing the SalixValeant merger MAC clause: Part 2 Market Realist
07:05PM  Parsing the SalixValeant merger MAC clause: Part 1 Market Realist
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.